1
Derived from payout historyIncome reliability
Income record needs more seasoning
REGN has a less proven income record. Treat the stated cadence as a starting point and verify issuer payout policy before relying on it.
Market dataIncome framework read
New Income ListingNasdaqUnited States
REGN
Regeneron Pharmaceuticals
Health CareNeeds manual reviewUnknown
Market Snapshot
US$618.03
+US$5.53 (90.29%)
NasdaqGS
Yield
0.61%
Rate US$3.76
Next Payment
Payment date passed
Ex-date 2026-05-20
52wk Position
33.70%
-24.73% below high
Updated just now
Decision Area
Distribution and DRIP Defense
Payout history, default DRIP coverage, and price creep pressure using market data where available.
Distribution Chart
Last 12 payments
Confirmed Expected
Coverage Ratio Test
DRIP defense check
- Cash
- US$94.00
- APR
- 0.152
- Coverage
- 0.152
Rung failed. Restore immediately or rebalance the holding.
Price Creep
Defended price ceiling
- Max defended
- US$94.00
- Cushion
- -US$524.03
- Cushion %
- -84.79%
Current US$618.03Break US$94.00
Smart Recommendation
REGN is not defended at these inputs; top up shares, lower TPR, or test alternatives.
Research Signals
Research in progress
DRIP availability
Not available
Tax character
Unknown
Distribution history
Payout cadence requires issuer verification
Growth-to-Income Holding
This is a growth-focused holding where current yield may not support near-term income goals. Use the Portfolio Conversion Tool to model when this position generates your target monthly income.
Open Portfolio Conversion ToolStructure Overview
This is a recently listed or newly income-initiating security where the payout history is limited or unproven. New income listings require additional due diligence: the stated distribution policy may not yet be tested through a full economic cycle, and early payout levels may be adjusted once the issuer establishes a sustainable base.
Canadian Planning Notes
- 1Treat new income listings as research items rather than plan-ready holdings until at least four consecutive distribution periods have been completed.
- 2Review the prospectus, issuer press releases, and earnings to verify whether the stated payout ratio and distribution policy are supported by current cash flows.
- 3Use the Dividend Compare Engine to place a new listing beside an established comparable before relying on the distribution in a monthly income plan.
Market Facts
Market Data
A factual market, distribution, valuation, and financial snapshot for this holding.
Canadian Context
Account placement
TFSA
Mixed-character distributions are usually easiest to handle in a TFSA because annual tax reporting is avoided.
RRSP: Also shelters distribution complexity.
Non-registered: Review T3 or issuer tax breakdown before using a taxable account.
Eligible dividend tax credit
- Total credit
- $345.27
- Effective rate
- 34.53%
Broker DRIP status
Questrade
Available
Wealthsimple
Plan-only
RBC Direct Investing
Available
TD Direct Investing
Available
U.S.-listed holdings can have withholding tax differences by account type. RRSP treatment is often more favorable than TFSA treatment.
Run Your Numbers
Carry this holding into a calculator
Use a planning tool that matches this holding's structure, payout timing, and income use case.
Related Holdings
This profile is informational only and does not constitute licensed financial advice. Signal values, planning notes, market data, and structure summaries may not reflect the most current issuer disclosures. Always verify current payout policy, ex-dividend dates, financial statements, and issuer communications before making any investment decision.